Sort by:

• Highly Influential Citations
• Citations
• Acceleration
• Velocity
• Recency

Learn More

[The safety and efficacy of sunitinib using a modified regimen (2 weeks on/1 week off) for treatment of metastatic renal cell carcinoma].

• Yoshikazu Togo, Kimihiro Shimatani, +21 authors Shingo Yamamoto
• Hinyokika kiyo. Acta urologica Japonica
• 2014

We prospectively investigated the safety and efficacy of sunitinib using a modified regimen (2 weeks on/1 week off) in 24 patients (22 males, 2 females ; age range 39-86 years, median 64 years) with… (More)

[A Case of Retroperitoneal Serous Cyst Treated by Open Fenestration : A Case Report].

• Kimihiro Shimatani, Yoshikazu Togo, +10 authors Shingo Yamamoto
• Hinyokika kiyo. Acta urologica Japonica
• 2015

A 47-year-old woman came to our hospital with left lower abdominal pain in April 2013. An abdominal computed tomographic (CT) examination revealed left hydronephrosis secondary to a 7 cm… (More)

[Clinical Study of Testicular Fasciotomy for Testicular Torsion].

• Seiji Nagasawa, Akihiro Kanematsu, +7 authors Shingo Yamamoto
• Hinyokika kiyo. Acta urologica Japonica
• 2017

Between November 2011 and November 2014, we performed a tunica albuginea incision with tunica vaginalis flap coverage (TAI＋TVFC) on 5 out of 15 patients who underwent surgery for testicular torsion.… (More)

Two cases of nonbacterial cystitis associated with nivolumab, the anti-programmed-death-receptor-1 inhibitor

• Kimihiro Shimatani, Tetsuro Yoshimoto, Yutaka Doi, Takashi Sonoda, Shingo Yamamoto, Akihiro Kanematsu
• Urology case reports
• 2018

Anti-programmed-death-receptor-1 (anti-PD1) inhibitor, nivolumab, is an immune checkpoint inhibitor, which has recently been widely used and has become a standard treatment for various cancers,… (More)

• ‹
• 1
• ›